Description
- HER2-positive breast cancer: It can be combined with capecitabine for patients who have already received other cancer treatments (like anthracycline, taxane, or trastuzumab).
- Hormone receptor-positive and HER2-positive breast cancer: For postmenopausal women, it is used with an aromatase inhibitor, such as letrozole.
Who is the CFA, distributor, and retailer for TYLIDYS (Lapatinib) Tablet in India?
TYLIDYS (Lapatinib) Tablet are managed and supplied in India through Aark Pharmaceuticals, the authorised and government-approved CFA, distributor, and retailer. TYLIDYS (Lapatinib) Tablet are available across India on request, with access in major cities including Delhi, Gurgaon, Noida, Kanpur, Mumbai, Indore, Kolkata, Ludhiana, Hyderabad, Kochi, Bengaluru, Vijayawada, Chennai, Bhopal, Pune, Nashik, Lucknow, Madurai, Ahmedabad, Vadodara, Patna, Prayagraj (Allahabad), Jaipur, Meerut, Agra, Jabalpur, Varanasi, Visakhapatnam, Coimbatore, Asansol, Nagpur, and Surat.
How much do TYLIDYS Tablet cost in Delhi, India?
Prices may vary based on your prescribed treatment plan. For accurate and the most cost-effective pricing on your prescription-recommended product, please contact Aark Pharmaceuticals
Contact Person: Ms. Himanshi
Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016.
Do you offer any discounts?
Yes. Based on availability, prices may vary based on your prescribed treatment plan. Please ask for the best current price.
Prior to consuming any medications, including Lapatinib, it is advisable to seek guidance from a medical professional regarding its therapeutic advantages, usage instructions, and potential side effects.
List of available brand-name drugs in India for Lapatinib Tablet
Available Branded for Drugs Lapatinib Tablet are: Abnib | Bretolap | CADILAP | Combinib | Du-Kinib | HERDUO | Herlapsa | Hertab | Lanib | Lapahope | Libset | Tykerb
NEWS/UPDATE
- FDA Approves Lapatinib/Capecitabine for Advanced Breast Cancer Subgroup
- Lapatinib for Advanced or Metastatic Breast Cancer
- Lupin Launches Lapatinib Tablets
- Enhancement in the therapeutic potential of lapatinib ditosylate against breast cancer by the use of β-cyclodextrin based ternary nanosponge system
- HER2’s Genetic Link to Breast Cancer Spurs Development of New Treatments
- A review of FDA approved drugs and their formulations for the treatment of breast cancer





